Citations 2
636 A phase 1, open-label, dose escalation and expansion study of CUE-102 monotherapy in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers
Margossian, Steven, Powderly, John , Gabrail, Nashat , Uboha, Nataliya V. , Ma, Wen , Jones, Jeremy , Alistar, Angela , Agensky, Laura, Goel, Apollina, Lynam, Reena, Moniz, Raymond J., Quayle, Steve, Rajan, Cynthia, Levisetti, Matteo, Jones, Jeremy C , Saenger, Yvonne M. , Selfridge, Jennifer Eva , Gong, Jun , Tine, Brian A. Van , Alese, Olatunji B. , Kim, Dae Won , Bekaii‐Saab, Tanios , Pienta, Kenneth J
Regular and Young Investigator Award Abstracts | November 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: A667-A667
717 Interim clinical update of the phase 1b trial of ATRC-101 as monotherapy or in combination with pembrolizumab for select advanced solid tumors
Weroha, S. John , Powderly, John , Valdes-Albini, Frances , Doroshow, Deborah B. , Recio‐Boiles, Alejandro , Xing, Yan, Khurana, Sudha, Isakoff, Steven J. , Chmielowski, Bartosz , Ulahannan, Susanna Varkey , Bekaii‐Saab, Tanios , Berlin, Jordan D. , Benjamin, Jonathan, Weinberg, Benjamin A.
Regular and Young Investigator Award Abstracts | November 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: A750-A750